What is CAPA in GMP?

Short answer

CAPA means Corrective Action and Preventive Action. In GMP, a corrective action addresses the cause of a detected problem to prevent recurrence. A preventive action addresses the cause of a potential problem to prevent occurrence.

A correction or containment deals with the immediate situation. CAPA should address the underlying cause and wider system risk. Not every event needs a separate CAPA record, but the decision and level of action should be justified by the investigation, impact and risk.

Regulatory guidance and the ICH Q10 model

EU GMP Chapter 1 is regulatory guidance. It expects appropriate corrective and preventive actions to be identified and taken following investigations, with their effectiveness monitored and assessed.

ICH Q10 describes a CAPA system covering issues arising from complaints, product rejection, non-conformance, recalls, deviations, audits, regulatory inspections and trends. ICH Q10 is a pharmaceutical quality-system model and should be applied alongside the applicable regional GMP requirements.

A robust CAPA process normally includes

A clear statement of the problem and its significance.

Immediate correction, containment or risk-control measures where needed.

An evidence-based investigation and justified root cause.

Assessment of the wider or systemic impact.

Actions that are directly linked to the identified cause or causes.

Defined owners, priorities, approvals and realistic target dates.

Assessment of related change control, validation, documentation and training needs.

Objective implementation evidence.

A pre-defined method for checking effectiveness after sufficient time or opportunity for recurrence.

Quality review and formal closure based on evidence.

Correction, corrective action and preventive action

Correction: fixes the immediate non-conformity or its effect.

Corrective action: removes or controls the cause of a detected problem to prevent recurrence.

Preventive action: removes or controls the cause of a potential problem to prevent occurrence.

These records should remain distinct enough to show what was done immediately, what addressed the cause and how effectiveness will be demonstrated.

Common weaknesses

Using retraining as the default action without showing that competence caused the problem.

Choosing actions before the investigation is complete.

Correcting the affected item but leaving the systemic cause unchanged.

Setting arbitrary dates that do not reflect risk, complexity or dependencies.

Closing an action on completion without checking whether it worked.

Repeated deviations indicating that previous CAPA was ineffective.

Questions to ask internally

Does each action address evidence from the investigation?

Are immediate corrections clearly separated from longer-term actions?

Have changes to procedures, systems, equipment, validation and training been assessed?

What objective evidence will demonstrate implementation?

When and how will effectiveness be evaluated?

How W2 can help

W2 Cleanroom Consulting can independently review CAPA logic, challenge weak root-cause links, assess remediation plans and help define proportionate implementation and effectiveness evidence. The client remains responsible for Quality approval, action ownership, licence obligations and regulatory correspondence.

Need help with a difficult or recurring CAPA?

Contact W2 Cleanroom Consulting at info@w2cleanrooms.com to discuss investigation review, inspection response or remediation support.

Prepared and reviewed by: W2 Cleanroom Consulting GMP team. Last reviewed: 24 July 2026.